Left Lane Capital — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
Renegade provides an ownership-based model with community and operational systems to support independent insurance agents in growing, operating, and exiting their agencies.
FintechInsurTechMarketplacesNew York, US
Board seatHarley Miller· per SEC Form D · $41.5M raise · filed Nov 2021
Co-investorsblue 9 capitalMetaPropMetaProp VenturesNFXTreasuryEx Nihilo
New York, US
Niklas de la Motte(Executive Officer, Director)William C. Shope, Jr.(Executive Officer, Director)Drew Sfugaras(Executive Officer)
Board seatHarley Miller· per SEC Form D · $40M raise · filed Sep 2021
APFusion is a B2B automotive marketplace that connects salvage yards with vendors to increase inventory availability and streamline parts ordering and management.
B2B MarketplacesSaaSUrbana, US
ALEX SMITH(Executive Officer, Director)Alex Smith(Founder)inROBERT A SMITH(Director)
Co-investorsFJ LabsBedrock CapitalM25
Black Crow provides AI-powered analytics and personalization software for e-commerce brands to understand customer behavior and deliver tailored shopping experiences.
AdTechAI & Machine LearningE-commerceMarketing TechNew York, US
Richard Harris(Executive Officer, Director)Joel Goldman(Founder)inDamon Tassone(Executive Officer, Director)
BoardShehzad Khan(Director)in
Co-investorsGood FriendsHabitat PartnersImaginary Venture CapitalInterlock PartnersPrimary Venture PartnersBloomberg Beta+2 more
Cricket Square, Grand Cayman
Mateus Carvalho Dantas(Executive Officer, Director)Andre Augusto Machado Santos(Executive Officer, Director)Nigel Eccles(Director)
Co-investors4M HoldingBullpen CapitalCourtside Ventures
Talkiatry is a telehealth platform that connects patients with psychiatrists for remote mental health care.
Digital HealthHealthtechMental HealthNew York, US
Robert Krayn(Executive Officer, Director)in
Co-investorsAndreessen HorowitzGreyMatterRelevance VenturesBlisceSofina
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.